{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:28:08Z","timestamp":1787020088426,"version":"build-2736575974"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Coordena\u00e7\u00e3o de Aperfeic\u0327oamento de Pessoal de N\u00edvel Superior"},{"name":"PDPG\u2014P\u00f3s-Doutorado Estrat\u00e9gico (PDPG-POSDOC), Coordena\u00e7\u00e3o de Aperfeic\u0327oamento de Pessoal de N\u00edvel Superior","award":["Edital 16\/2022\u2014File N\u00ba 88887.759036\/2022-00"],"award-info":[{"award-number":["Edital 16\/2022\u2014File N\u00ba 88887.759036\/2022-00"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-03920-w","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T08:41:34Z","timestamp":1744188094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unveiling the molecular epidemiology of Pseudomonas aeruginosa in lung infections among cystic fibrosis patients in the Brazilian Amazon"],"prefix":"10.1186","volume":"25","author":[{"given":"Maria Isabel Montoril","family":"Gouveia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edilene","family":"do Socorro Nascimento Falc\u00e3o Sarges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herald Souza","family":"dos Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle Melo","family":"Sardinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pabllo Antonny Silva","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layana Rufino","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Jess\u00e9 Abrah\u00e3o","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Vinicios Hino","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Judith Pires Garcia","family":"Quaresma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle Murici","family":"Brasiliense","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana Nepomuceno Godim Costa","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla Val\u00e9ria Batista","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Corr\u00eaa","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"issue":"17","key":"3920_CR1","doi-asserted-by":"publisher","first-page":"9599","DOI":"10.3390\/ijms25179599","volume":"25","author":"P Trouv\u00e9","year":"2024","unstructured":"Trouv\u00e9 P, Saint Pierre A, F\u00e9rec C. Cystic Fibrosis: A Journey through Time and Hope. Int J Mol Sci. 2024;25(17):9599.","journal-title":"Int J Mol Sci"},{"key":"3920_CR2","doi-asserted-by":"publisher","first-page":"1405376","DOI":"10.3389\/fimmu.2024.1405376","volume":"15","author":"R Nickerson","year":"2024","unstructured":"Nickerson R, Thornton CS, Johnston B, Lee AHY, Cheng Z. Pseudomonas aeruginosa in chronic lung disease: untangling the dysregulated host immune response. Front Immunol. 2024;15:1405376.","journal-title":"Front Immunol"},{"issue":"1","key":"3920_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41392-022-01056-1","volume":"7","author":"S Qin","year":"2022","unstructured":"Qin S, Xiao W, Zhou C, Pu Q, Deng X, Lan L, et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct Target Ther. 2022;7(1):199.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"3920_CR4","first-page":"719","volume":"9","author":"V Cepas","year":"2020","unstructured":"Cepas V, Soto SM. Relationship between virulence and resistance among gram-negative bacteria. Antibiot Basel Switz. 2020;9(10):719.","journal-title":"Antibiot Basel Switz"},{"issue":"1","key":"3920_CR5","doi-asserted-by":"publisher","first-page":"e0222423","DOI":"10.1128\/spectrum.02224-23","volume":"12","author":"T Wu","year":"2024","unstructured":"Wu T, Zhang Z, Li T, Dong X, Wu D, Zhu L, et al. The type III secretion system facilitates systemic infections of Pseudomonas aeruginosa in the clinic. Microbiol Spectr. 2024;12(1):e0222423.","journal-title":"Microbiol Spectr"},{"key":"3920_CR6","doi-asserted-by":"publisher","first-page":"104907","DOI":"10.1016\/j.micpath.2021.104907","volume":"155","author":"G Horna","year":"2021","unstructured":"Horna G, Ruiz J. Type 3 secretion system as an anti-Pseudomonal target. Microb Pathog. 2021;155:104907.","journal-title":"Microb Pathog"},{"issue":"4","key":"3920_CR7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3343\/alm.2014.34.4.286","volume":"34","author":"HH Cho","year":"2014","unstructured":"Cho HH, Kwon KC, Kim S, Koo SH. Correlation between virulence genotype and fluoroquinolone resistance in carbapenem-resistant Pseudomonas aeruginosa. Ann Lab Med. 2014;34(4):286\u201392.","journal-title":"Ann Lab Med"},{"issue":"1","key":"3920_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/CCM.0b013e318298a86f","volume":"42","author":"E Sullivan","year":"2014","unstructured":"Sullivan E, Bensman J, Lou M, Agnello M, Shriner K, Wong-Beringer A. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa. Crit Care Med. 2014;42(1):48\u201356.","journal-title":"Crit Care Med"},{"issue":"4","key":"3920_CR9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/cid\/ciu866","volume":"60","author":"C Pe\u00f1a","year":"2015","unstructured":"Pe\u00f1a C, Cabot G, G\u00f3mez-Zorrilla S, Zamorano L, Ocampo-Sosa A, Murillas J, et al. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections. Clin Infect Dis Off Publ Infect Dis Soc Am. 2015;60(4):539\u201348.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"12","key":"3920_CR10","doi-asserted-by":"publisher","first-page":"e01586","DOI":"10.1128\/AAC.01586-17","volume":"61","author":"I S\u00e1nchez-Diener","year":"2017","unstructured":"S\u00e1nchez-Diener I, Zamorano L, L\u00f3pez-Causap\u00e9 C, Cabot G, Mulet X, Pe\u00f1a C, et al. Interplay among resistance profiles, high-risk clones, and virulence in the caenorhabditis elegans pseudomonas aeruginosa infection model. Antimicrob Agents Chemother. 2017;61(12):e01586-e1617.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3920_CR11","doi-asserted-by":"publisher","first-page":"e01759","DOI":"10.1128\/AAC.01759-19","volume":"64","author":"R Recio","year":"2020","unstructured":"Recio R, Manche\u00f1o M, Viedma E, Villa J, Orellana M\u00c1, Lora-Tamayo J, et al. Predictors of mortality in bloodstream infections caused by pseudomonas aeruginosa and impact of antimicrobial resistance and bacterial virulence. Antimicrob Agents Chemother. 2020;64(2):e01759-e1819.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3920_CR12","doi-asserted-by":"publisher","first-page":"10874","DOI":"10.1038\/s41598-019-47303-4","volume":"9","author":"G Horna","year":"2019","unstructured":"Horna G, Amaro C, Palacios A, Guerra H, Ruiz J. High frequency of the exoU+\/exoS+ genotype associated with multidrug-resistant \u201chigh-risk clones\u201d of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals. Sci Rep. 2019;9(1):10874.","journal-title":"Sci Rep"},{"key":"3920_CR13","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.2147\/IDR.S273759","volume":"13","author":"SNF Sarges Edo","year":"2020","unstructured":"Sarges Edo SNF, Rodrigues YC, Furlaneto IP, de Melo MVH, da C Brabo GL, Lopes KCM, et al. Pseudomonas aeruginosa type III secretion system virulotypes and their association with clinical features of cystic fibrosis patients. Infect Drug Resist. 2020;13:3771\u201381.","journal-title":"Infect Drug Resist."},{"issue":"10","key":"3920_CR14","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.3390\/microorganisms12102051","volume":"12","author":"M Rossitto","year":"2024","unstructured":"Rossitto M, Fox V, Vrenna G, Tuccio Guarna Assanti V, Essa N, Lepanto MS, et al. The challenging life of mutators: how pseudomonas aeruginosa survives between persistence and evolution in cystic fibrosis lung. Microorganisms. 2024;12(10):2051.","journal-title":"\u00a0Microorganisms."},{"issue":"6","key":"3920_CR15","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jcf.2018.08.014","volume":"17","author":"TJ Kidd","year":"2018","unstructured":"Kidd TJ, Canton R, Ekkelenkamp M, Johansen HK, Gilligan P, LiPuma JJ, et al. Defining antimicrobial resistance in cystic fibrosis. J Cyst Fibros Off J Eur Cyst Fibros Soc. 2018;17(6):696\u2013704.","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"issue":"11","key":"3920_CR16","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1128\/JCM.00459-09","volume":"47","author":"DJ Waine","year":"2009","unstructured":"Waine DJ, Honeybourne D, Smith EG, Whitehouse JL, Dowson CG. Cross-sectional and longitudinal multilocus sequence typing of pseudomonas aeruginosa in cystic fibrosis sputum samples. J Clin Microbiol. 2009;47(11):3444\u20138.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"3920_CR17","doi-asserted-by":"publisher","first-page":"e00019","DOI":"10.1128\/CMR.00019-18","volume":"31","author":"MD Parkins","year":"2018","unstructured":"Parkins MD, Somayaji R, Waters VJ. Epidemiology, biology, and impact of clonal pseudomonas aeruginosa infections in cystic fibrosis. Clin Microbiol Rev. 2018;31(4):e00019-18.","journal-title":"Clin Microbiol Rev."},{"issue":"10","key":"3920_CR18","first-page":"983","volume":"13","author":"YC Rodrigues","year":"2024","unstructured":"Rodrigues YC, Silva MJA, Dos Reis HS, Dos Santos PAS, Sardinha DM, Gouveia MIM, et al. Molecular epidemiology of pseudomonas aeruginosa in brazil: a systematic review and meta-analysis. Antibiot Basel Switz. 2024;13(10):983.","journal-title":"Antibiot Basel Switz"},{"issue":"4","key":"3920_CR19","first-page":"469","volume":"30","author":"A Oliver","year":"2024","unstructured":"Oliver A, Rojo-Molinero E, Arca-Suarez J, Be\u015fli Y, Bogaerts P, Cant\u00f3n R, et al. Pseudomonasaeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID\/ISARPAE Group. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2024;30(4):469\u201380.","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"5","key":"3920_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/1348-0421.12776","volume":"64","author":"T Sawa","year":"2020","unstructured":"Sawa T, Momiyama K, Mihara T, Kainuma A, Kinoshita M, Moriyama K. Molecular epidemiology of clinically high-risk Pseudomonas aeruginosa strains: Practical overview. Microbiol Immunol. 2020;64(5):331\u201344.","journal-title":"Microbiol Immunol"},{"issue":"2","key":"3920_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3390\/microorganisms9020359","volume":"9","author":"B Kocsis","year":"2021","unstructured":"Kocsis B, Guly\u00e1s D, Szab\u00f3 D. Diversity and Distribution of Resistance Markers in Pseudomonas aeruginosa International High-Risk Clones. Microorganisms. 2021;9(2):359.","journal-title":"Microorganisms"},{"key":"3920_CR22","doi-asserted-by":"publisher","first-page":"105513","DOI":"10.1016\/j.meegid.2023.105513","volume":"115","author":"C Dupont","year":"2023","unstructured":"Dupont C, Aujoulat F, Benaoudia M, Jumas-Bilak E, Chiron R, Marchandin H. Highly diverse dynamics of Pseudomonas aeruginosa colonization from initial detection in cystic fibrosis patients: A 7-year longitudinal genetic diversity study. Infect Genet Evol. 2023;115:105513.","journal-title":"Infect Genet Evol"},{"issue":"6","key":"3920_CR23","doi-asserted-by":"publisher","first-page":"e0157189","DOI":"10.1371\/journal.pone.0157189","volume":"11","author":"R van Mansfeld","year":"2016","unstructured":"van Mansfeld R, de Vrankrijker A, Brimicombe R, Heijerman H, Teding van Berkhout F, Spitoni C, et al. The effect of strict segregation on pseudomonas aeruginosa in cystic fibrosis patients. PloS One. 2016;11(6):e0157189.","journal-title":"PloS One."},{"issue":"12","key":"3920_CR24","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1128\/JCM.01462-09","volume":"47","author":"R van Mansfeld","year":"2009","unstructured":"van Mansfeld R, Willems R, Brimicombe R, Heijerman H, van Berkhout FT, Wolfs T, et al. Pseudomonas aeruginosa genotype prevalence in Dutch cystic fibrosis patients and age dependency of colonization by various P. aeruginosa sequence types. J Clin Microbiol. 2009;47(12):4096\u2013101.","journal-title":"J Clin Microbiol."},{"issue":"3","key":"3920_CR25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ijantimicag.2017.03.034","volume":"50","author":"C L\u00f3pez-Causap\u00e9","year":"2017","unstructured":"L\u00f3pez-Causap\u00e9 C, de Dios-Caballero J, Cobo M, Escribano A, Asensio \u00d3, Oliver A, et al. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study. Int J Antimicrob Agents. 2017;50(3):334\u201341.","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"3920_CR26","doi-asserted-by":"publisher","first-page":"e0208013","DOI":"10.1371\/journal.pone.0208013","volume":"13","author":"NC Ca\u00e7ador","year":"2018","unstructured":"Ca\u00e7ador NC, Capizzani CP da C, Torres LAGMM, Galetti R, Ciofu O, Darini AL da C, et al. Adaptation of Pseudomonas aeruginosa to the chronic phenotype by mutations in the algTmucABD operon in isolates from Brazilian cystic fibrosis patients. PLOS ONE. 2018;13(11):e0208013.","journal-title":"PLOS ONE."},{"issue":"12","key":"3920_CR27","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/apm.12463","volume":"123","author":"AG Ferreira","year":"2015","unstructured":"Ferreira AG, Le\u00e3o RS, Carvalho-Assef APD, da Silva \u00c9ADSR, de C\u00e1ssia Firmida M, Folescu TW, et al. Low-level resistance and clonal diversity of Pseudomonas aeruginosa among chronically colonized cystic fibrosis patients. APMIS. 2015;123(12):1061\u20138.","journal-title":"APMIS."},{"issue":"11","key":"3920_CR28","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1128\/JCM.39.11.3976-3981.2001","volume":"39","author":"S Silbert","year":"2001","unstructured":"Silbert S, Barth AL, Sader HS. Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients. J Clin Microbiol. 2001;39(11):3976\u201381.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"3920_CR29","first-page":"462","volume":"14","author":"EG Stehling","year":"2010","unstructured":"Stehling EG, Leite DS, Silveira WD. Molecular typing and biological characteristics of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Brazil. Braz J Infect Dis Off Publ Braz Soc Infect Dis. 2010;14(5):462\u20137.","journal-title":"Braz J Infect Dis Off Publ Braz Soc Infect Dis"},{"issue":"2","key":"3920_CR30","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s00284-020-02337-0","volume":"78","author":"MM Almeida","year":"2021","unstructured":"Almeida MM, Freitas MT, Folescu TW, Firmida MC, Carvalho-Assef APD, Marques EA, et al. Carbapenem-Resistant Pseudomonas aeruginosa in Chronic Lung Infection: Current Resistance Profile and Hypermutability in Patients with Cystic Fibrosis. Curr Microbiol. 2021;78(2):696\u2013704.","journal-title":"Curr Microbiol"},{"issue":"4","key":"3920_CR31","first-page":"495","volume":"39","author":"LVRF da Silva","year":"2013","unstructured":"da Silva LVRF, de A Ferreira F, Reis FJC, de Britto MCA, Levy CE, Clark O, et al. Pseudomonas aeruginosa infection in patients with cystic fibrosis: scientific evidence regarding clinical impact, diagnosis, and treatment. J Bras Pneumol Publica\u00e7a\u030bo Of Soc Bras Pneumol E Tisilogia. 2013;39(4):495\u2013512.","journal-title":"J Bras Pneumol Publica\u00e7a\u030bo Of Soc Bras Pneumol E Tisilogia."},{"key":"3920_CR32","unstructured":"Brazil. Conass Informa n. 75\/2024 \u2013 Publicada a Portaria Conjunta SAES\/SECTICS n. 5 que aprova o Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas da Fibrose C\u00edstica. 2024. Available from: https:\/\/www.conass.org.br\/conass-informa-n-75-2024-publicada-a-portaria-conjunta-saes-sectics-n-5-que-aprova-o-protocolo-clinico-e-diretrizes-terapeuticas-da-fibrose-cistica\/. Cited 2024 Nov 30."},{"key":"3920_CR33","unstructured":"Pereira C, Neder J. Diretrizes para Testes de Fun\u00e7\u00e3o Pulmonar. Vol. Vol 28 (Suppl 3). Sociedade Brasileira de Pneumologia e Tisiologia; 2002."},{"key":"3920_CR34","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 34th ed. Malvern, PA: Clinical and Laboratory Standards Institute; 2024. (CLSI supplement M100)."},{"issue":"3","key":"3920_CR35","first-page":"268","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"11","key":"3920_CR36","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1128\/AAC.01481-13","volume":"57","author":"X Mulet","year":"2013","unstructured":"Mulet X, Cabot G, Ocampo-Sosa AA, Dom\u00ednguez MA, Zamorano L, Juan C, et al. Biological markers of Pseudomonas aeruginosa epidemic high-risk clones. Antimicrob Agents Chemother. 2013;57(11):5527\u201335.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"3920_CR37","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.1128\/JCM.42.12.5783-5792.2004","volume":"42","author":"S Finnan","year":"2004","unstructured":"Finnan S, Morrissey JP, O\u2019Gara F, Boyd EF. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment. J Clin Microbiol. 2004;42(12):5783\u201392.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"3920_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/02713680500536746","volume":"31","author":"H Zhu","year":"2006","unstructured":"Zhu H, Conibear TCR, Bandara R, Aliwarga Y, Stapleton F, Willcox MDP. Type III secretion system-associated toxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis. Curr Eye Res. 2006;31(4):297\u2013306.","journal-title":"Curr Eye Res"},{"issue":"9","key":"3920_CR39","doi-asserted-by":"publisher","first-page":"e0238741","DOI":"10.1371\/journal.pone.0238741","volume":"15","author":"YC Rodrigues","year":"2020","unstructured":"Rodrigues YC, Furlaneto IP, Maciel AHP, Quaresma AJPG, de Matos ECO, Concei\u00e7\u00e3o ML, et al. High prevalence of atypical virulotype and genetically diverse background among Pseudomonas aeruginosa isolates from a referral hospital in the Brazilian Amazon. PLoS ONE. 2020;15(9):e0238741.","journal-title":"PLoS ONE"},{"issue":"12","key":"3920_CR40","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3390\/pathogens13121030","volume":"13","author":"CG Nolasco-Romero","year":"2024","unstructured":"Nolasco-Romero CG, Prado-Galbarro FJ, Jimenez-Juarez RN, Gomez-Ramirez U, Cancino-D\u00edaz JC, L\u00f3pez-Marceliano B, et al. The exoS, exoT, exoU and exoY Virulotypes of the type 3 secretion system in multidrug resistant pseudomonas aeruginosa as a death risk factor in pediatric patients. Pathogens. 2024;13(12):1030.","journal-title":"Pathogens"},{"issue":"12","key":"3920_CR41","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1128\/JCM.42.12.5644-5649.2004","volume":"42","author":"B Curran","year":"2004","unstructured":"Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol. 2004;42(12):5644\u20139.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"3920_CR42","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.3390\/microorganisms11082069","volume":"11","author":"PAS Dos Santos","year":"2023","unstructured":"Dos Santos PAS, Rodrigues YC, Marcon DJ, Lobato ARF, Cazuza TB, Gouveia MIM, et al. Endemic high-risk clone ST277 is related to the spread of SPM-1-producing pseudomonas aeruginosa during the COVID-19 pandemic period in Northern Brazil. Microorganisms. 2023;11(8):2069.","journal-title":"Microorganisms"},{"key":"3920_CR43","doi-asserted-by":"publisher","first-page":"124","DOI":"10.12688\/wellcomeopenres.14826.1","volume":"3","author":"KA Jolley","year":"2018","unstructured":"Jolley KA, Bray JE, Maiden MCJ. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res. 2018;3:124.","journal-title":"Wellcome Open Res."},{"key":"3920_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1471-2105-13-87","volume":"13","author":"AP Francisco","year":"2012","unstructured":"Francisco AP, Vaz C, Monteiro PT, Melo-Cristino J, Ramirez M, Carri\u00e7o JA. PHYLOViZ: phylogenetic inference and data visualization for sequence based typing methods. BMC Bioinformatics. 2012;13:87.","journal-title":"BMC Bioinformatics"},{"key":"3920_CR45","volume-title":"Patient Registry 2021 Annual Data Report","author":"Cystic Fibrosis Foundation","year":"2022","unstructured":"Cystic Fibrosis Foundation. Patient Registry 2021 Annual Data Report. Bethesda, Maryland: Cystic Fibrosis Foundation; 2022."},{"key":"3920_CR46","unstructured":"Zolin A, Adamoli A, Bakkeheim E, van Rens J et al. Annual Report 2022. European Cystic Fibrosis Society; 2024."},{"issue":"6","key":"3920_CR47","first-page":"CD004197","volume":"6","author":"SC Langton Hewer","year":"2023","unstructured":"Langton Hewer SC, Smith S, Rowbotham NJ, Yule A, Smyth AR. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Cochrane Database Syst Rev. 2023;6(6):CD004197.","journal-title":"Cochrane Database Syst Rev."},{"issue":"2","key":"3920_CR48","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1183\/09031936.01.00068901","volume":"18","author":"J Navarro","year":"2001","unstructured":"Navarro J, Rainisio M, Harms HK, Hodson ME, Koch C, Mastella G, et al. Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis. Eur Respir J. 2001;18(2):298\u2013305.","journal-title":"Eur Respir J."},{"issue":"3","key":"3920_CR49","doi-asserted-by":"publisher","first-page":"e00138","DOI":"10.1128\/CMR.00138-18","volume":"32","author":"S Malhotra","year":"2019","unstructured":"Malhotra S, Hayes D, Wozniak DJ. Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface. Clin Microbiol Rev. 2019;32(3):e00138-e218.","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"3920_CR50","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S2213-2600(14)70100-6","volume":"2","author":"E Kerem","year":"2014","unstructured":"Kerem E, Konstan MW, De Boeck K, Accurso FJ, Sermet-Gaudelus I, Wilschanski M, et al. Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Respir Med. 2014;2(7):539\u201347.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"3920_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1055\/s-0042-1758732","volume":"44","author":"CS Thornton","year":"2023","unstructured":"Thornton CS, Parkins MD. Microbial Epidemiology of the Cystic Fibrosis Airways: Past, Present, and Future. Semin Respir Crit Care Med. 2023;44(2):269\u201386.","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"3920_CR52","first-page":"266","volume":"19","author":"H Hu","year":"2013","unstructured":"Hu H, Harmer C, Anuj S, Wainwright CE, Manos J, Cheney J, et al. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2013;19(3):266\u201372.","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"18","key":"3920_CR53","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s40265-021-01635-6","volume":"81","author":"D Reynolds","year":"2021","unstructured":"Reynolds D, Kollef M. The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update. Drugs. 2021;81(18):2117\u201331.","journal-title":"Drugs"},{"issue":"1","key":"3920_CR54","doi-asserted-by":"publisher","first-page":"9056","DOI":"10.1038\/s41598-024-59658-4","volume":"14","author":"J Singh","year":"2024","unstructured":"Singh J, Hunt S, Simonds S, Boyton C, Middleton A, Elias M, et al. The changing epidemiology of pulmonary infection in children and adolescents with cystic fibrosis: an 18-year experience. Sci Rep. 2024;14(1):9056.","journal-title":"Sci Rep"},{"issue":"6","key":"3920_CR55","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.3390\/jcm13061711","volume":"13","author":"A Vitiello","year":"2024","unstructured":"Vitiello A, Blasi F, Sabbatucci M, Zovi A, Miele F, Ponzo A, et al. The Impact of Antimicrobial Resistance in Cystic Fibrosis. J Clin Med. 2024;13(6):1711.","journal-title":"J Clin Med"},{"issue":"2","key":"3920_CR56","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/antibiotics12020217","volume":"12","author":"EP Perikleous","year":"2023","unstructured":"Perikleous EP, Gkentzi D, Bertzouanis A, Paraskakis E, Sovtic A, Fouzas S. Antibiotic Resistance in Patients with Cystic Fibrosis: Past, Present, and Future. Antibiotics. 2023;12(2):217.","journal-title":"Antibiotics"},{"key":"3920_CR57","doi-asserted-by":"publisher","first-page":"105461","DOI":"10.1016\/j.micpath.2022.105461","volume":"165","author":"P Bonyadi","year":"2022","unstructured":"Bonyadi P, Saleh NT, Dehghani M, Yamini M, Amini K. Prevalence of antibiotic resistance of Pseudomonas aeruginosa in cystic fibrosis infection: A systematic review and meta-analysis. Microb Pathog. 2022;165:105461.","journal-title":"Microb Pathog"},{"issue":"5","key":"3920_CR58","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41579-020-00477-5","volume":"19","author":"E Rossi","year":"2021","unstructured":"Rossi E, La Rosa R, Bartell JA, Marvig RL, Haagensen JAJ, Sommer LM, et al. Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis. Nat Rev Microbiol. 2021;19(5):331\u201342.","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"3920_CR59","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.3390\/microorganisms11092366","volume":"11","author":"PAS Dos Santos","year":"2023","unstructured":"Dos Santos PAS, Silva MJA, Gouveia MIM, Lima LNGC, Quaresma AJPG, De Lima PDL, et al. The prevalence of metallo-beta-lactamese-(M\u03b2L)-Producing Pseudomonas aeruginosa Isolates in Brazil: a systematic review and meta-analysis. Microorganisms. 2023;11(9):2366.","journal-title":"Microorganisms"},{"issue":"Pt 8","key":"3920_CR60","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1099\/jmm.0.018283-0","volume":"59","author":"RS Bradbury","year":"2010","unstructured":"Bradbury RS, Roddam LF, Merritt A, Reid DW, Champion AC. Virulence gene distribution in clinical, nosocomial and environmental isolates of Pseudomonas aeruginosa. J Med Microbiol. 2010;59(Pt 8):881\u201390.","journal-title":"J Med Microbiol"},{"issue":"6","key":"3920_CR61","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1186\/s13054-014-0668-9","volume":"18","author":"T Sawa","year":"2014","unstructured":"Sawa T, Shimizu M, Moriyama K, Wiener-Kronish JP. Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review. Crit Care. 2014;18(6):668.","journal-title":"Crit Care"},{"issue":"10","key":"3920_CR62","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3855\/jidc.10675","volume":"13","author":"C Elmouaden","year":"2019","unstructured":"Elmouaden C, Laglaoui A, Ennanei L, Bakkali M, Abid M. Virulence genes and antibiotic resistance of Pseudomonas aeruginosa isolated from patients in the Northwestern of Morocco. J Infect Dev Ctries. 2019;13(10):892\u20138.","journal-title":"J Infect Dev Ctries"},{"issue":"3","key":"3920_CR63","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1590\/S1517-83822010000300008","volume":"41","author":"I Mitov","year":"2010","unstructured":"Mitov I, Strateva T, Markova B. Prevalence of virulence genes among bulgarian nosocomial and cystic fibrosis isolates of pseudomonas aeruginosa. Braz J Microbiol. 2010;41(3):588\u201395.","journal-title":"Braz J Microbiol"},{"key":"3920_CR64","doi-asserted-by":"crossref","unstructured":"Luo M, Li S, Luo W. Comparative analysis of antibiotic susceptibility patterns and clinical features of mucoid and non-mucoid Pseudomonas aeruginosa infections: a retrospective study. Front Public Health. 2024;12. Available from:\u00a0https:\/\/www.frontiersin.org\/journals\/public-health\/articles\/10.3389\/fpubh.2024.1333477\/full. Cited 2024 Nov 30.","DOI":"10.3389\/fpubh.2024.1333477"},{"issue":"11","key":"3920_CR65","first-page":"1561","volume":"12","author":"G Chich\u00f3n","year":"2023","unstructured":"Chich\u00f3n G, L\u00f3pez M, de Toro M, Ruiz-Rold\u00e1n L, Rojo-Bezares B, S\u00e1enz Y. Spread of pseudomonas aeruginosa ST274 clone in different niches: resistome, virulome, and phylogenetic relationship. Antibiot Basel Switz. 2023;12(11):1561.","journal-title":"Antibiot Basel Switz"},{"issue":"6","key":"3920_CR66","doi-asserted-by":"publisher","first-page":"106196","DOI":"10.1016\/j.ijantimicag.2020.106196","volume":"56","author":"E Del Barrio-Tofi\u00f1o","year":"2020","unstructured":"Del Barrio-Tofi\u00f1o E, L\u00f3pez-Causap\u00e9 C, Oliver A. Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired \u03b2-lactamases: 2020 update. Int J Antimicrob Agents. 2020;56(6):106196.","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"3920_CR67","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jiac.2018.03.008","volume":"24","author":"A Kainuma","year":"2018","unstructured":"Kainuma A, Momiyama K, Kimura T, Akiyama K, Inoue K, Naito Y, et al. An outbreak of fluoroquinolone-resistant Pseudomonas aeruginosa ST357 harboring the exoU gene. J Infect Chemother Off J Jpn Soc Chemother. 2018;24(8):615\u201322.","journal-title":"J Infect Chemother Off J Jpn Soc Chemother"},{"issue":"9","key":"3920_CR68","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3390\/pathogens13090719","volume":"13","author":"T Strateva","year":"2024","unstructured":"Strateva T, Stratev A, Peykov S. Genomic insights into vietnamese extended-spectrum \u03b2-lactamase-9-producing extensively drug-resistant pseudomonas aeruginosa isolates belonging to the high-risk clone ST357 obtained from bulgarian intensive care unit patients. Pathog Basel Switz. 2024;13(9):719.","journal-title":"Pathog Basel Switz"},{"key":"3920_CR69","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jhin.2021.05.006","volume":"115","author":"MP Freire","year":"2021","unstructured":"Freire MP, Camargo CH, Yamada AY, Nagamori FO, Reusing Junior JO, Spad\u00e3o F, et al. Critical points and potential pitfalls of outbreak of IMP-1-producing carbapenem-resistant Pseudomonas aeruginosa among kidney transplant recipients: a case-control study. J Hosp Infect. 2021;115:83\u201392.","journal-title":"J Hosp Infect"},{"issue":"12","key":"3920_CR70","doi-asserted-by":"publisher","first-page":"6349","DOI":"10.1128\/AAC.01388-12","volume":"56","author":"G Cabot","year":"2012","unstructured":"Cabot G, Ocampo-Sosa AA, Dom\u00ednguez MA, Gago JF, Juan C, Tubau F, et al. Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones. Antimicrob Agents Chemother. 2012;56(12):6349\u201357.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3920_CR71","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.diagmicrobio.2017.06.008","volume":"89","author":"S Balero de Paula","year":"2017","unstructured":"Balero de Paula S, Cay\u00f4 R, Streling AP, Silva Nodari C, Pereira Matos A, Eches Perugini MR, et al. Detection of blaVIM-7 in an extensively drug-resistant Pseudomonas aeruginosa isolate belonging to ST1284 in Brazil. Diagn Microbiol Infect Dis. 2017;89(1):80\u20132.","journal-title":"Diagn Microbiol Infect Dis."},{"key":"3920_CR72","unstructured":"Baleivanualala SC, Matanitobua S, Soqo V, Smita S, Limaono J, Sharma SC, et al. Molecular and clinical epidemiology of carbapenem resistant Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacterales in Fiji: a multicentre prospective observational study. Lancet Reg Health \u2013 West Pac [Internet]. 2024 Jun 1;47. Available from: https:\/\/www.thelancet.com\/journals\/lanwpc\/article\/PIIS2666-6065(24)00089-0\/fulltext. Cited 2024 Nov 30."},{"issue":"6","key":"3920_CR73","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/jac\/dkac084","volume":"77","author":"R Cabrera","year":"2022","unstructured":"Cabrera R, Fern\u00e1ndez-Barat L, V\u00e1zquez N, Alcaraz-Serrano V, Bueno-Freire L, Amaro R, et al. Resistance mechanisms and molecular epidemiology of Pseudomonas aeruginosa strains from patients with bronchiectasis. J Antimicrob Chemother. 2022;77(6):1600\u201310.","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"3920_CR74","doi-asserted-by":"publisher","first-page":"e00480","DOI":"10.1128\/aac.00480-23","volume":"67","author":"L Deroche","year":"2023","unstructured":"Deroche L, Aranzana-Climent V, Rozenholc A, Prouvensier L, Darnaud L, Gr\u00e9goire N, et al. Characterization of Pseudomonas aeruginosa resistance to ceftolozane-tazobactam due to ampC and\/or ampD mutations observed during treatment using semi-mechanistic PKPD modeling. Antimicrob Agents Chemother. 2023;67(10):e00480-e523.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"3920_CR75","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1093\/jac\/dkab188","volume":"76","author":"P Urbanowicz","year":"2021","unstructured":"Urbanowicz P, Izdebski R, Baraniak A, \u017babicka D, Hryniewicz W, Gniadkowski M. Molecular and genomic epidemiology of VIM\/IMP-like metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa genotypes in Poland. J Antimicrob Chemother. 2021;76(9):2273\u201384.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"3920_CR76","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s10661-023-11344-0","volume":"195","author":"MS Ramos","year":"2023","unstructured":"Ramos MS, Furlan JPR, Dos Santos LDR, Rosa R da S, Savazzi EA, Stehling EG. Patterns of antimicrobial resistance and metal tolerance in environmental Pseudomonas aeruginosa isolates and the genomic characterization of the rare O6\/ST900 clone. Environ Monit Assess. 2023;195(6):713.","journal-title":"Environ Monit Assess."},{"issue":"7","key":"3920_CR77","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s10096-011-1483-8","volume":"31","author":"A Burkett","year":"2012","unstructured":"Burkett A, Vandemheen KL, Giesbrecht-Lewis T, Ramotar K, Ferris W, Chan F, et al. Persistency of Pseudomonas aeruginosa in sputum cultures and clinical outcomes in adult patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2012;31(7):1603\u201310.","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03920-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-03920-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03920-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T01:16:40Z","timestamp":1745284600000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-03920-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3920"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-03920-w","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"1 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The samples included in this study were obtained during routine laboratory procedures at the CF reference center. Consent for participation was obtained from all included patients upon written signature of informed consent form. All data collection and experiments related to this study were performed in accordance with Brazilian guidelines and regulations (Resolution CNS n\u00ba 196\/96), as well as the Declaration of Helsinki. This study was approved by the Ethics Committee of the HUJBB\/UFPA (Approval no. 1.910.716) and was registered with the National System for the Management of Genetic Heritage and Associated Traditional Knowledge (SisGen; registration no. AF44CCB).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"203"}}